CURRICULUM VITAE

RELEVANT QUALIFICATIONS:

A GRADUATE OF MEDICAL UNIVERSITY IN WARSAW (1977-1983)

RESEARCH EXPERIENCE

My research interest include: diagnosis and treatment of pulmonary diseases, especially asthma and COPD, specific immunotherapy of allergic diseases, biologics and primary immunodeficiencies. In the area of my interests are also viral infections. In addition, interest in pharmacoeconomics include the cost of diseases and the relations between clinical and economic effectiveness. I am author of about 400 publications. I lead 30 clinical trials (II&III phases) in the areas of respiratory and allergic diseases.

My experience in editing include:

- Editor-in-Chief of Journal of Health Policy&Outcomes Research

- Editor -in- Chief of Alergologia I Immunologia Wspólczesna

According to the Web of Science core collection report of December 10, 2020 my h index is 7 and the sum of times cited is 292. Please find below the list of selected publications from 2013-2020.

LIST OF SELECTED PUBLICATIONS

1. Karina Jahnz-Rózyk Ewa Wiesik-Szewczyk Jacek Rolinski Maciej Siedlar et al.: Secondary immunodeficiencies with predominant antibody deficiency: multidisciplinary perspectives of Polish expert, Cent Eur J Immunol 2019; 45 (3): 334-341, DOI: https://doi.org/10.5114/ceji.2020.101265

2. Kwiecien I, RutkowskaE, Klos K, Wiesik-Szewczyk E., Jahnz-Rózyk , Chcialowski A: Maturation of T and B lymphocytes in the assessment of the immuno status in Covid-19 patients.Cells2020, 9, 2615; doi:10.3390/cells9122615

3. Wiesik-Szewczyk E, Soldacki D, Paczek L, Jahnz-Rózyk K. Facilitated Subcutaneous Immunoglobulin Replacement Therapy in Clinical Practice: A Two Center, Long-Term Retrospective Observation in Adults With Primary Immunodeficiencies. Front Immunol. 2020 May 20;11:981. doi: 10.3389/fimmu.2020.00981. PMID: 32670265; PMCID: PMC7326142.

4. Wiesik-Szewczyk E, Felis-Giemza A, Dziuk M, Jahnz-Rózyk K. Schnitzler Syndrome in a 27-Year-Old Man: Diagnostic and Therapeutic Dilemma in Adult Auto-Inflammatory Syndromes A Case Report and Literature Review. Int J Gen Med. 2020 Sep 25;13:713-719. doi: 10.2147/IJGM.S265482. PMID: 33061540; PMCID: PMC7532303.

5. Nowicki RJ, Trzeciak M, Rudnicka L, Szepietowski J, Kulus M, Kupczyk M, Mastalerz-Migas A, Peregud-Pogorzelski J, Jahnz-Rózyk K, Narbutt J, Czarnecka-Operacz M, Czajkowski R, Grubska-Suchanek E, Krasowska D, Krecisz B, Kowalewski C, Lesiak A, Olszewska M, Samochocki Z, Spiewak R, Wilkowska A. Biological drugs in the treatment of atopic dermatitis - current recommendations of the Polish Dermatological Society, the Polish Society of Allergology, the Polish Pediatric Society and the Polish Society of Family Medicine. Postepy Dermatol Alergol. 2020 Oct;37(5):617-624. doi: 10.5114/ada.2020.100496. Epub 2020 Nov 7. PMID: 33239998; PMCID: PMC7675073.

6. Zietkiewicz M, Wiesik-Szewczyk E, Matyja-Bednarczyk A, Napiórkowska-Baran K, Zdrojewski Z, Jahnz-Rózyk K. Shorter Diagnostic Delay in Polish Adult Patients With Common Variable Immunodeficiency and Symptom Onset After 1999. Front Immunol. 2020 May 27;11:982. doi: 10.3389/fimmu.2020.00982. PMID: 32655544; PMCID: PMC7326034.

7. Wiesik-Szewczyk E, Jahnz-Rózyk K. From infections to autoimmunity: Diagnostic challenges in common variable immunodeficiency. World J Clin Cases. 2020 Sep 26;8(18):3942-3955. doi: 10.12998/wjcc.v8.i18.3942. PMID: 33024751; PMCID: PMC7520788.

8. Wiesik-Szewczyk E, Wolska-Kusnierz B, Jahnz-Rózyk K. Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome persisting to adulthood - an example of a diagnostic and therapeutic challenge. Reumatologia. 2019;57(5):292-296. doi: 10.5114/reum.2019.89523. Epub 2019 Oct 31. PMID: 31844343; PMCID: PMC6911254

9. Raciborski F, Jahnz-Rozyk K, Klak A, Sybilski AJ, Grabczewska AM, Brzozowska M, Sliwczyñski AM. Epidemiology and direct costs of atopic dermatitis in Poland based on the National Health Fund register (2008-2017). Postepy Dermatol Alergol. 2019 Dec;36(6):727-733. doi: 10.5114/ada.2018.79099. Epub 2018 Oct 19. PMID: 31998002; PMCID: PMC6986289.

10. Sokolowski RA, Rzad M, Zaremba A, Czerniak S, Jahnz-Rózyk K. Rapid oncological diagnosis of lung cancer patients - specific facility experience. Adv Respir Med. 2019;87(2):96-102. doi: 10.5603/ARM.2019.0016. PMID: 31038720.

11.Wiesik-Szewczyk E, Jahnz-Rózyk K. A case report of pregnancy in a patient with common variable immunodeficiency emphasizing the need for personalized immunoglobulin replacement. Medicine (Baltimore). 2018 Nov;97(44):e12804. doi: 10.1097/MD.0000000000012804. PMID: 30383634; PMCID: PMC6221563.

12.Wiesik-Szewczyk E, Zietkiewicz M, Matyja-Bednarczyk A, Napiórkowska-Baran K, Suchanek H, Jahnz-Rózyk K. The first Polish cohort of adult patients with common variable immunodeficiency from 4 specialized centers: do we provide standards of care? Pol Arch Intern Med. 2018 Sep 28;128(9):563-566. doi: 10.20452/pamw.4315. Epub 2018 Aug 16. PMID: 30113020.

13.Jahnz-Rózyk K, Lis J, Warchol M, Kucharczyk A. Clinical and economic impact of a one-year treatment with omalizumab in patients with severe allergic asthma within a drug programme in Poland. BMC Pulm Med. 2018 Mar 16;18(1):48. doi: 10.1186/s12890-018-0610-z. PMID: 29548318; PMCID: PMC5857072.

14. Jahnz-Rozyk K, Raciborski F, Sliwczynski AM, Klak A, Pinkas J. Anaphylaxis in Poland: the epidemiology and direct costs. Postepy Dermatol Alergol. 2017 Dec;34(6):573-579. doi: 10.5114/pdia.2017.70361.

15.Jahnz-Rózyk K, Kawalec P, Malinowski K, Czok K Drug Policy in Poland. Value Health Reg Issues. 2017 Sep;13:23-26. doi: 10.1016/j.vhri.2017.07.001.

16.Jahnz-Rózyk K, Szepiel P. Early impact of treatment with tiotropium, long-acting anticholinergic preparation, in patients with COPD - real-life experience from an observational study. Int J Chron Obstruct Pulmon Dis. 2015 Mar 18;10:613-23. doi: 10.2147/COPD.S77144. PMID: 25834420; PMCID: PMC4370685.

17.Jahnz-Rózyk K, Kucharczyk A, Warchol M, Radziwilska-Muc A, Wladysiuk M, Plisko R. Koszty astmy w Polsce w 2012 roku [The costs of asthma in Poland in 2012]. Pol Merkur Lekarski. 2015 Aug;39(230):91-5. Polish. PMID: 26319382.

18.Sliwczynski A, Brzozowska M, Iltchew P, Czeleko T, Kucharczyk A, Jedrzejczyk T, Jahnz-Rózyk K, Marczak M. Epidemiology of asthma in Poland in urban and rural areas, based on provided health care services. Pneumonol Alergol Pol. 2015;83(3):178-87. doi: 10.5603/PiAP.2015.0029. PMID: 26050977

19.Wiesik-Szewczyk E, Jahnz-Rózyk K. Autoimmunizacyjne ukladowe choroby tkanki lacznej a szczepienia ochronne [Autoimmune connective tissue diseases and vaccination]. Postepy Hig Med Dosw (Online). 2015 Dec 31;69:1530-8. Polish. PMID: 27259225.

20.Bebrysz M, Wladysiuk M, Fedyna M, Haldas M, Rutkowski J, Jahnz-Rozyk K. Calculating Indirect Costs - Differences Caused by Various Approaches to Unit Costs. Results of Move to Work Study (M2W). Value Health. 2014 Nov;17(7):A773. doi: 10.1016/j.jval.2014.08.327. Epub 2014 Oct 26. PMID: 27202852.

21.Wisniewska N, Jahnz-Rozyk KM, Paluchowska EB, Owczarek W, Szkultecka-Debek M. Direct Costs of Treatment of Skin Drug Reactions Induced by Antibiotics in Perspective of Public Payer and Service Provider. Value Health. 2014 Nov;17(7):A805. doi: 10.1016/j.jval.2014.08.516. Epub 2014 Oct 26. PMID: 27203034.

22.Kovács G, Kaló Z, Jahnz-Rozyk K, Kyncl J, Csohan A, Pistol A, Leleka M, Kipshakbaev R, Durand L, Macabeo B. Medical and economic burden of influenza in the elderly population in central and eastern European countries. Hum Vaccin Immunother. 2014;10(2):428-40. doi: 10.4161/hv.26886. Epub 2013 Oct 28. PMID: 24165394; PMCID: PMC4185899.

23. [The Polish Task Force position statement on safety of biologic treatment with monoclonal antibodies and soluble receptors]. Jahnz-Rozyk K, Wiesik-Szewczyk E; Grupa Ekspertów.. Pol Merkur Lekarski. 2014 Jul;37(217):5-9

24.Tichopad A, Roberts C, Gembula I, Hajek P, Skoczynska A, Hryniewicz W, Jahnz-Rozyk K, Prymula R, Solovic I, Kolek V. Clinical and economic burden of community-acquired pneumonia among adults in the Czech Republic, Hungary, Poland and Slovakia. PLoS One. 2013 Aug 6;8(8):e71375. doi: 10.1371/journal.pone.0071375. PMID: 23940743; PMCID: PMC3735497.

25.Rivaroxaban for thromboprophylaxis in acutely ill medical patients. Cohen AT, Spiro TE, Büller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Spyropoulos AC, Tapson V; MAGELLAN Investigators. N Engl J Med. 2013 Feb 7;368(6):513-23. doi: 10.1056/NEJMoa1111096.